First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?
暂无分享,去创建一个
[1] Harold Lehmann,et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. , 2014, The New England journal of medicine.
[2] Amit R. Patel,et al. Mechanistic Insights and Characterization of Sickle Cell Disease–Associated Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.
[3] D. Calvet,et al. Sickle‐cell disease stroke throughout life: A retrospective study in an adult referral center , 2014, American journal of hematology.
[4] C. Delacourt,et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. , 2011, Blood.
[5] A. Fischer,et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. , 2007, Blood.
[6] R. Adams,et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future , 2006, The Lancet Neurology.
[7] J. Curé,et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. , 2002, Blood.
[8] Scott T. Miller,et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.
[9] Scott T. Miller,et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. , 1995, The Journal of pediatrics.
[10] O. Platt,et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.
[11] S. Leikin,et al. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. , 1989, Pediatrics.